3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
8
Carcinoma
5
Squamous Cell Carcinoma of Head and Neck
3
Recurrence
3
Mouth Neoplasms
3
Colorectal Neoplasms
3
Adenocarcinoma
3
Skin Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell
2
Laryngeal Neoplasms
2
Glioblastoma
2
Fallopian Tube Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Squamous Cell
2
Breast Neoplasms
2
Vaccinia
1
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Sinonasal Squamous Cell Carcinoma
1
Sarcoma
1
Resectable Non-small Cell Lung Cancer
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Interventions
Platinum
3
Pemetrexed
3
Cisplatin
3
1,2-diaminocyclohexaneplatinum II citrate
3
pembrolizumab
2
Radiotherapy
2
Radiation
2
cediranib
1
atezolizumab
1
Radiotherapy, Intensity-Modulated
1
Pharmacogenomic Testing
1
Combined Modality Therapy
1
Cerebral Decortication
1
Carboplatin
1
Brentuximab Vedotin
1
Blood Component Removal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
cemiplimab
×
30 days
×
Clear all
No trials found.